HHealth Read More Study links diabetes to worse long COVID health outcomesJune 29, 2026 People with diabetes who have had COVID-19 tend to recover more slowly, experience more long COVID complications, have…
HHealth Read More The Race to Build the Next Generation of Weight Loss Pills Is Heating UpJune 27, 2026 The future of weight loss treatment is looking to get easier to swallow. Several research teams and pharmaceutical…
HHealth Read More Single DNA injection provides long-lasting weight loss in mouse studyJune 26, 2026 Scientists at The Wistar Institute have shown that a single injection of a small, circular piece of genetic…
MMedication Read More GLP-1 weight loss pills may be bad thing for job insurance coverageJune 26, 2026 The new GLP-1 pills are likely to boost consumer demand for these popular weight-loss drugs. But it could…
FFitness Read More Chester County has a new outdoor gym as a result of a national fitness campaignJune 26, 2026 Chester County has an elaborate new outdoor gym, installed as part of a national campaign to encourage exercise…
HHealth Read More Neuroticism and adversity dominate depression and anxiety risk in UK Biobank studyJune 26, 2026 A 13-year UK Biobank analysis suggests that neuroticism, adversity, and other psychosocial pressures may explain more of the…
HHealth Read More Exercise, not liraglutide alone, drives vascular gains after obesity-related weight lossJune 26, 2026 A year-long trial suggests that, after major weight loss, movement may do what medication alone cannot: improve key…
MMedication Read More Health Canada Approves Zepbound for OSA in Adults With ObesityJune 25, 2026 Key takeaways: Health Canada approved Zepbound (tirzepatide injection) for adults with obesity and moderate to severe OSA. In…
HHealth Read More Bariatric surgery linked to higher risk of developing alcohol problemsJune 25, 2026 Your body absorbs alcohol much more rapidly after bariatric surgery. Patients need to know this when they choose…
MMedication Read More Nutrition matters for GLP-1 drug users June 25, 2026 We noticed it right away in 2005 when the first GLP-1 medication for people with diabetes hit the…
MMedication Read More Health Canada approves weight-loss drug for sleep apnea in patients with obesityJune 24, 2026 TORONTO — Health Canada has approved weight-loss drug Zepbound for treating obstructive sleep apnea in adults with obesity.…
SScience Read More USC study links modified Mediterranean diet to longer lifespanJune 24, 2026 A plant- and fish-based, low-protein diet paired with small amounts of an amino acid commonly found in eggs,…